SciRhom
Company

Last deal

$68.19M
Local Amount - EUR 63M

Amount

Series A

Stage

09.07.2024

Date

3

all rounds

$84.63M

Total amount

date founded

Financing round

General

About Company
SciRhom is a biotech enterprise that develops game-changing therapies for autoimmune diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2016

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Founded in 2016, SciRhom GmbH is a biotech start-up that develops first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signaling pathways, including TNF-alpha signaling. The company's therapeutic antibodies are designed to improve autoimmune disease therapies and provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. With a well-established network of experts and a focus on preclinical and early clinical development, SciRhom is poised to transform the lives of patients with life-threatening autoimmune diseases.
Contacts
Similar Companies
1000
Biotherapeutics

Biotherapeutics

BioTherapeutics Inc. (BTI) develops small-molecule drugs for autoimmune and metabolic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Blacksburg, VA, USA

total rounds

2

total raised

$800K
Cyxone

Cyxone

Cyxone is a biotech company that develops drugs to improve the quality of life for people with severe autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Malmö, Sweden
Dualyx

Dualyx

Dualyx develops biologic drugs for autoimmunity therapies with improved patient outcomes.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Ghent, Belgium

total rounds

2

total raised

$43.44M
Boaoxin

Boaoxin

Biosion is a biotech company that develops biologics to treat various diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Nanjing, Jiangsu, China

total rounds

3

total raised

$31.36M

Financials

Funding Rounds
3
3

Number of Funding Rounds

$84.63M

Money Raised

Their latest funding was raised on 09.07.2024. Their latest investor Andera Partners. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
09.07.2024
8
$68.19M
Local Amount - EUR 63M
30.11.2021
$9.07M
Local Amount - EUR 8M
01.01.2017
2
$7.37M
Local Amount - EUR 7M
Andera Partners

Andera Partners

Andera Partners is a venture capital firm that invests in various sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Paris, France

total rounds

1

total raised

$48.5M

count Of Investments

169

count Of Exists

39
MIG

MIG

MIG is a leading German VC investor focused on early to mid-stage technology and life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Neuherberg, Oberschleißheim, Germany

count Of Investments

73

count Of Exists

8
Kurma Partners

Kurma Partners

Kurma Partners specializes in financing healthcare and biotechnology innovation.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Health Care, Financial Services

Location

Paris, France

count Of Investments

89

count Of Exists

6
Wellington Partners

Wellington Partners

Wellington Partners is a venture capital firm that invests in technology and life sciences companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Biotechnology

Location

Munich, Germany

count Of Investments

207

count Of Exists

54
High-Tech Grunderfonds

High-Tech Grunderfonds

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bonn, Germany

count Of Investments

834

count Of Exists

107
Hospital for Special Surgery

Hospital for Special Surgery

HSS is a leading academic medical center specializing in musculoskeletal health.

Sector

Health Care Providers

Subsector

Health Care Facilities

Location

New York, NY, USA

total rounds

3

total raised

$36.6M

count Of Investments

5
Co-Investors
Investors
9
6

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
Andera Partners

Andera Partners

Andera Partners is a venture capital firm that invests in various sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Paris, France

total rounds

1

total raised

$48.5M

count Of Investments

169

count Of Exists

39
Olivier Litzka

Olivier Litzka

Olivier Litzka has been a partner with Paris-based Edmond de Rothschild Investment Partners (EdRIP) since 2006. He invests primarily in European biotechnology and medtech companies as well as some investments in the United States. In addition to Endosense, he serves on the boards of Noxxon Pharma, ProBioDrug, SuperSonic Imagine, Sapiens Steering Brain Stimulation and JenaValve Technologies. Up until its acquisition by AstraZeneca, he was also a member of the board of Novexel (France). Before joining EdRIP, Litzka spent six years with 3i's life science venture capital practice, based first in Munich and then in Paris. In this position, he served on the boards of several portfolio companies and made a range of international investments. Before joining 3i in 2000, he worked as a strategy consultant with Mercer Management Consulting for several years, both in Munich and Paris. Litzka holds a Ph.D. in molecular microbiology from the Institut für Mikrobiologie at the University of Munich and did his scientific research work over several years in Munich and Oxford.

current job

Andera Partners
Andera Partners
Bayern Kapital

Bayern Kapital

Bayern Kapital is a venture capital firm that finances research and development for high-tech companies in Bavaria.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Banking

Location

Landshut, Germany

count Of Investments

202

count Of Exists

24
PhiFund Ventures

PhiFund Ventures

Phi Fund Ventures is a Taiwan-based venture capital firm that focuses on transforming healthcare companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Health Care

count Of Investments

4

People

Employee Profiles
3
Andreas Jenne

Andreas Jenne

Co-Founder & Managing Director

Jens Ruhe

Jens Ruhe

Co-Founder, Managing Director, Chief Executive Officer

Matthias Schneider

Matthias Schneider

Founder & Chief Scientific Officer

Activity

Recent News
4
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month